Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

NCT02284529 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Stage-Ⅱ Colorectal Cancer

Interventions

DRUG: Orectalip

Sponsor

Sinphar Pharmaceutical Co., Ltd

Collaborators

[object Object]